Stanley J. Meresman - 15 Jun 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Jun 2022, 17:44:07 UTC
Prior SEC filing
20 May 2022
Next SEC filing
27 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John Saia, as attorney-in-fact for Stanley J Meresman

Key filing fact

Stanley J. Meresman filed Form 4 for Guardant Health, Inc. (GH) on 17 Jun 2022.

Key facts

  • This page summarizes Stanley J. Meresman's Form 4 filing for Guardant Health, Inc. (GH).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Jun 2022, 17:44.

Change

  • Previous filing in this sequence was filed on 20 May 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GH transaction

COMMON STOCK

Options Exercise

Transaction value
$0
Shares
+1,814
Change %
+45%
Price
$0.000000
Shares after
5,873
Date
15 Jun 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GH transaction Derivative

RESTRICTED STOCK UNITS

Options Exercise

Transaction value
$0
Shares
-1,814
Change %
-100%
Price
$0.000000*
Shares after
0
Date
15 Jun 2022
Ownership
Direct
Underlying class
COMMON STOCK
Underlying amount
1,814
Exercise price
$0.000000
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2022.

Footnote F2

Not applicable for Restricted Stock Units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .